High Tide (HITI) said Monday it signed a deal to acquire 51% of Purecan for roughly 4.8 million euros ($4.9 million), with the option to buy the remaining interest in the medical cannabis supplier in Germany.
The purchase price comprises 2.4 million euros in common shares, 1.2 million euros in cash and 1.2 million euros in a promissory note, the company said.
The transaction includes High Tide's European wholesale and import license, warehousing and logistics infrastructure, and in-development telemedicine platform, High Tide Chief Executive Raj Grover said in a statement.
High Tide said the acquisition in Germany positions it for potential expansion into other European medical cannabis markets.
The deal is expected to close in the coming weeks, subject to TSX Venture Exchange approval and other closing conditions, the company added.
Shares of the company fell 2.6% in recent trading.
Price: 3.01, Change: -0.08, Percent Change: -2.59
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。